You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 1, July 2, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Osteoarthritis
 •Pain
 •Alert me on articles by topic

Pain Management in Patients With Osteoarthritis

Since this article does not have an abstract, we have provided the first 118 words of the full text and any section headings.

To the Editor: In his Clinical Crossroads article about a 57-year-old man with arthritis, Dr Lonner1 stated that cyclooxygenase-2 (COX-2) selective inhibitors are as effective as nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), but may have "decreased toxicity on non-target tissues such as the gastric mucosa, although at 15 to 20 times the cost." In support of this assertion he cites data from the Celecoxib Long-term Arthritis Safety Study (CLASS).2 In fact, however, a later analysis revealed that 12 months of celecoxib was no safer than other NSAIDs, and the US Food and Drug Administration disagreed with the manufacturer's claim that celecoxib was safer.3

Thomas E. Finucane, MD
Division of Geriatric Medicine and Gerontology
Johns Hopkins Geriatrics Center
Baltimore, Md

1. Lonner JH. A 57-year-old man with osteoarthritis of the knee. JAMA. 2003;289:1016-1025. FREE FULL TEXT
2. Silverstein FE, Faich G, Goldstein JL, et al, Celecoxib Long-term Arthritis Safety Study. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA. 2000;284:1247-1255. FREE FULL TEXT
3. Witter J. Celebrex Capsules (Celecoxib): Medical Officer Review. Available at: http://www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_03_med.pdf. Accessed June 16, 2003.

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290:36.


RELATED ARTICLES

Pain Management in Patients With Osteoarthritis
Barry Egener
JAMA. 2003;290(1):36.
EXTRACT | FULL TEXT  

Pain Management in Patients With Osteoarthritis—Reply
Jess H. Lonner
JAMA. 2003;290(1):36.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.